- Home
- ZCMD vs GRCE Comparison
ZCMD vs GRCE Comparison
Compare ZCMD & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- GRCE
- Stock Information
- Founded
- ZCMD 2012
- GRCE 2002
- Country
- ZCMD China
- GRCE United States
- Employees
- ZCMD N/A
- GRCE N/A
- Industry
- ZCMD Other Consumer Services
- GRCE
- Sector
- ZCMD Real Estate
- GRCE
- Exchange
- ZCMD Nasdaq
- GRCE NYSE
- Market Cap
- ZCMD 29.0M
- GRCE 42.1M
- IPO Year
- ZCMD 2020
- GRCE N/A
- Fundamental
- Price
- ZCMD $1.18
- GRCE $3.00
- Analyst Decision
- ZCMD
- GRCE Strong Buy
- Analyst Count
- ZCMD 0
- GRCE 1
- Target Price
- ZCMD N/A
- GRCE $12.00
- AVG Volume (30 Days)
- ZCMD 650.7K
- GRCE 60.2K
- Earning Date
- ZCMD 01-01-0001
- GRCE 08-15-2025
- Dividend Yield
- ZCMD N/A
- GRCE N/A
- EPS Growth
- ZCMD N/A
- GRCE N/A
- EPS
- ZCMD N/A
- GRCE N/A
- Revenue
- ZCMD $15,864,773.00
- GRCE N/A
- Revenue This Year
- ZCMD N/A
- GRCE N/A
- Revenue Next Year
- ZCMD N/A
- GRCE N/A
- P/E Ratio
- ZCMD N/A
- GRCE N/A
- Revenue Growth
- ZCMD N/A
- GRCE N/A
- 52 Week Low
- ZCMD $0.95
- GRCE $1.75
- 52 Week High
- ZCMD $2.97
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- ZCMD 49.32
- GRCE N/A
- Support Level
- ZCMD $1.12
- GRCE N/A
- Resistance Level
- ZCMD $1.24
- GRCE N/A
- Average True Range (ATR)
- ZCMD 0.13
- GRCE 0.00
- MACD
- ZCMD -0.00
- GRCE 0.00
- Stochastic Oscillator
- ZCMD 26.71
- GRCE 0.00
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.